Disease related to transplantation

Summary

Disease related to transplantation (MONDO:0700220) is a disease (an umbrella term covering 5 Mondo subtypes). A subtype of disease of primarily extrinsic mechanism — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: 1-9 / 100 000 (Europe) [Orphanet-validated]
• Umbrella term: 5 Mondo subtypes

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

Type	Class	Value	Geography	Validation
Point prevalence	1-9 / 100 000	9	Europe	Validated

Identifiers

Disease identifiers

Field	Value
Canonical name	disease related to transplantation
Mondo ID	MONDO:0700220
Orphanet	306644
UMLS	C1998172
MedGen	745174
Is cancer (heuristic)	no

Disease family

An umbrella term covering 5 Mondo subtypes.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › disease related to transplantation

Related subtypes (6): infectious disease, post-infectious disorder, poisoning, radiation-induced disorder, iatrogenic disease, occupational disorder

Subtypes (5): posttransplant acute limbic encephalitis, post-transplant lymphoproliferative disease, disease related to solid organ transplantation, disease related to hematopoietic stem cell transplant, transplant rejection

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.